Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 193 entries
Sorted by: Best Match Show Resources per page
Tendon transfer for irreparable rotator cuff tears: indications and surgical rationale.

Muscles, ligaments and tendons journal

Merolla G, Chillemi C, Franceschini V, Cerciello S, Ippolito G, Paladini P, Porcellini G.
PMID: 25767779
Muscles Ligaments Tendons J. 2015 Feb 05;4(4):425-32. eCollection 2014.

BACKGROUND: treatment of symptomatic irreparable rotator cuff tears is extremely challenging because, at present, there are no ideal solutions to this problem. Many patients respond favorably to nonsurgical treatment. However, when conservative measures fail to improve the patient's pain...

Cite
Merolla G, Chillemi C, Franceschini V, et al. Tendon transfer for irreparable rotator cuff tears: indications and surgical rationale. Muscles Ligaments Tendons J. 2015;4(4):425-32
Merolla, G., Chillemi, C., Franceschini, V., Cerciello, S., Ippolito, G., Paladini, P., & Porcellini, G. (2014). Tendon transfer for irreparable rotator cuff tears: indications and surgical rationale. Muscles, ligaments and tendons journal, 4(4), 425-32.
Merolla, Giovanni, et al. "Tendon transfer for irreparable rotator cuff tears: indications and surgical rationale." Muscles, ligaments and tendons journal vol. 4,4 (2014): 425-32.
Merolla G, Chillemi C, Franceschini V, Cerciello S, Ippolito G, Paladini P, Porcellini G. Tendon transfer for irreparable rotator cuff tears: indications and surgical rationale. Muscles Ligaments Tendons J. 2015 Feb 05;4(4):425-32. eCollection 2014. PMID: 25767779; PMCID: PMC4327351.
Copy Download .nbib Format: NLM
The May-Hegglin anomaly in a kidney transplant recipient.

NDT plus

Fabbian F, Ricci F, De Giorgi A, Forcellini S, Scanelli G.
PMID: 28657035
NDT Plus. 2010 Jun;3(3):312. doi: 10.1093/ndtplus/sfq001. Epub 2010 Feb 28.

No abstract available.

Cite
Fabbian F, Ricci F, De Giorgi A, et al. The May-Hegglin anomaly in a kidney transplant recipient. NDT Plus. 2010;3(3):312doi: 10.1093/ndtplus/sfq001.
Fabbian, F., Ricci, F., De Giorgi, A., Forcellini, S., & Scanelli, G. (2010). The May-Hegglin anomaly in a kidney transplant recipient. NDT plus, 3(3), 312. https://doi.org/10.1093/ndtplus/sfq001
Fabbian, Fabio, et al. "The May-Hegglin anomaly in a kidney transplant recipient." NDT plus vol. 3,3 (2010): 312. doi: https://doi.org/10.1093/ndtplus/sfq001
Fabbian F, Ricci F, De Giorgi A, Forcellini S, Scanelli G. The May-Hegglin anomaly in a kidney transplant recipient. NDT Plus. 2010 Jun;3(3):312. doi: 10.1093/ndtplus/sfq001. Epub 2010 Feb 28. PMID: 28657035; PMCID: PMC5477938.
Copy Download .nbib Format: NLM
Variations in inflammatory genes are associated with periodontitis.

Immunity & ageing : I & A

Ianni M, Bruzzesi G, Pugliese D, Porcellini E, Carbone I, Schiavone A, Licastro F.
PMID: 24274085
Immun Ageing. 2013 Oct 01;10(1):39. doi: 10.1186/1742-4933-10-39.

BACKGROUND: Periodontitis is a multi-factorial disease and several risk-factors such as infections, inflammatory responses, oral hygiene, smoke, aging and individual predisposition are involved in the disease. Pathogens trigger chronic inflammation with cytokines release which in turn leads to the...

Cite
Ianni M, Bruzzesi G, Pugliese D, et al. Variations in inflammatory genes are associated with periodontitis. Immun Ageing. 2013;10(1):39doi: 10.1186/1742-4933-10-39.
Ianni, M., Bruzzesi, G., Pugliese, D., Porcellini, E., Carbone, I., Schiavone, A., & Licastro, F. (2013). Variations in inflammatory genes are associated with periodontitis. Immunity & ageing : I & A, 10(1), 39. https://doi.org/10.1186/1742-4933-10-39
Ianni, Manuela, et al. "Variations in inflammatory genes are associated with periodontitis." Immunity & ageing : I & A vol. 10,1 (2013): 39. doi: https://doi.org/10.1186/1742-4933-10-39
Ianni M, Bruzzesi G, Pugliese D, Porcellini E, Carbone I, Schiavone A, Licastro F. Variations in inflammatory genes are associated with periodontitis. Immun Ageing. 2013 Oct 01;10(1):39. doi: 10.1186/1742-4933-10-39. PMID: 24274085; PMCID: PMC3850543.
Copy Download .nbib Format: NLM
Robotics in shoulder rehabilitation.

Muscles, ligaments and tendons journal

Sicuri C, Porcellini G, Merolla G.
PMID: 25332937
Muscles Ligaments Tendons J. 2014 Jul 14;4(2):207-13. eCollection 2014 Apr.

In the last few decades, several researches have been conducted in the field of robotic rehabilitation to meet the intensive, repetitive and task-oriented training, with the goal to recover the motor function. Up to now, robotic rehabilitation studies of...

Cite
Sicuri C, Porcellini G, Merolla G. Robotics in shoulder rehabilitation. Muscles Ligaments Tendons J. 2014;4(2):207-13
Sicuri, C., Porcellini, G., & Merolla, G. (2014). Robotics in shoulder rehabilitation. Muscles, ligaments and tendons journal, 4(2), 207-13.
Sicuri, Chiara, et al. "Robotics in shoulder rehabilitation." Muscles, ligaments and tendons journal vol. 4,2 (2014): 207-13.
Sicuri C, Porcellini G, Merolla G. Robotics in shoulder rehabilitation. Muscles Ligaments Tendons J. 2014 Jul 14;4(2):207-13. eCollection 2014 Apr. PMID: 25332937; PMCID: PMC4187609.
Copy Download .nbib Format: NLM
The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms.

Oncoimmunology

Porcellini S, Asperti C, Valentinis B, Tiziano E, Mangia P, Bordignon C, Rizzardi GP, Traversari C.
PMID: 26451306
Oncoimmunology. 2015 Jul 01;4(10):e1041700. doi: 10.1080/2162402X.2015.1041700. eCollection 2015 Oct.

NGR-TNF is a vascular targeting agent in advanced clinical development, coupling tumor necrosis factor-α (TNF) with the CNGRCG peptide, which targets a CD13 isoform specifically expressed by angiogenic vessels. Antitumor efficacy of NGR-TNF has been described in different transplantation...

Cite
Porcellini S, Asperti C, Valentinis B, et al. The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms. Oncoimmunology. 2015;4(10):e1041700doi: 10.1080/2162402X.2015.1041700.
Porcellini, S., Asperti, C., Valentinis, B., Tiziano, E., Mangia, P., Bordignon, C., Rizzardi, G. P., & Traversari, C. (2015). The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms. Oncoimmunology, 4(10), e1041700. https://doi.org/10.1080/2162402X.2015.1041700
Porcellini, Simona, et al. "The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms." Oncoimmunology vol. 4,10 (2015): e1041700. doi: https://doi.org/10.1080/2162402X.2015.1041700
Porcellini S, Asperti C, Valentinis B, Tiziano E, Mangia P, Bordignon C, Rizzardi GP, Traversari C. The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms. Oncoimmunology. 2015 Jul 01;4(10):e1041700. doi: 10.1080/2162402X.2015.1041700. eCollection 2015 Oct. PMID: 26451306; PMCID: PMC4589061.
Copy Download .nbib Format: NLM
Persistent infections, immune-senescence and Alzheimer's disease.

Oncoscience

Licastro F, Porcellini E.
PMID: 27489858
Oncoscience. 2016 Jun 30;3(5):135-42. doi: 10.18632/oncoscience.309. eCollection 2016.

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia. Classical hallmarks of AD such as amyloid deposition and neurofibrillary tangles do not completely explain AD pathogenesis. Recent investigations proposed Aβ peptide as an...

Cite
Licastro F, Porcellini E. Persistent infections, immune-senescence and Alzheimer's disease. Oncoscience. 2016;3(5):135-42doi: 10.18632/oncoscience.309.
Licastro, F., & Porcellini, E. (2016). Persistent infections, immune-senescence and Alzheimer's disease. Oncoscience, 3(5), 135-42. https://doi.org/10.18632/oncoscience.309
Licastro, Federico, and Porcellini, Elisa. "Persistent infections, immune-senescence and Alzheimer's disease." Oncoscience vol. 3,5 (2016): 135-42. doi: https://doi.org/10.18632/oncoscience.309
Licastro F, Porcellini E. Persistent infections, immune-senescence and Alzheimer's disease. Oncoscience. 2016 Jun 30;3(5):135-42. doi: 10.18632/oncoscience.309. eCollection 2016. PMID: 27489858; PMCID: PMC4965253.
Copy Download .nbib Format: NLM
Reverse Shoulder Arthroplasty in Patients Aged Sixty Years Old or Younger: Are we Really Doing the Best?.

Translational medicine @ UniSa

Merolla G, Porcellini G.
PMID: 24809038
Transl Med UniSa. 2014 Apr 24;9:66-7. eCollection 2014 Apr.

No abstract available.

Cite
Merolla G, Porcellini G. Reverse Shoulder Arthroplasty in Patients Aged Sixty Years Old or Younger: Are we Really Doing the Best?. Transl Med UniSa. 2014;9:66-7
Merolla, G., & Porcellini, G. (2014). Reverse Shoulder Arthroplasty in Patients Aged Sixty Years Old or Younger: Are we Really Doing the Best?. Translational medicine @ UniSa, 966-7.
Merolla, G, and Porcellini, G. "Reverse Shoulder Arthroplasty in Patients Aged Sixty Years Old or Younger: Are we Really Doing the Best?." Translational medicine @ UniSa vol. 9 (2014): 66-7.
Merolla G, Porcellini G. Reverse Shoulder Arthroplasty in Patients Aged Sixty Years Old or Younger: Are we Really Doing the Best?. Transl Med UniSa. 2014 Apr 24;9:66-7. eCollection 2014 Apr. PMID: 24809038; PMCID: PMC4012378.
Copy Download .nbib Format: NLM
Application of Chiral Sulfides to Catalytic Asymmetric Aziridination and Cyclopropanation with In Situ Generation of the Diazo Compound We thank Avecia (M.P.), the EPSRC (M.F.), the EU for a Marie Curie Fellowship (E.A.; HPMF-CT-1999-00076), Lu'an Teacher's College and the Education Minister of The Peoples Republic of China (G.F.), and Sheffield University for financial support. We thank Dr. J. Blacker (Avecia), Dr. R. V. H. Jones (Zeneca Agrochemicals), and Dr. R. Fieldhouse (Zeneca Agrochemica.

Angewandte Chemie (International ed. in English)

Aggarwal VK, Alonso E, Fang G, Ferrara M, Hynd G, Porcelloni M.
PMID: 11317294
Angew Chem Int Ed Engl. 2001 Apr 17;40(8):1433-1436.

No abstract available.

Cite
Aggarwal VK, Alonso E, Fang G, et al. Application of Chiral Sulfides to Catalytic Asymmetric Aziridination and Cyclopropanation with In Situ Generation of the Diazo Compound We thank Avecia (M.P.), the EPSRC (M.F.), the EU for a Marie Curie Fellowship (E.A.; HPMF-CT-1999-00076), Lu'an Teacher's College and the Education Minister of The Peoples Republic of China (G.F.), and Sheffield University for financial support. We thank Dr. J. Blacker (Avecia), Dr. R. V. H. Jones (Zeneca Agrochemicals), and Dr. R. Fieldhouse (Zeneca Agrochemica. Angew Chem Int Ed Engl. 2001;40(8):1433-1436
Aggarwal, V. K., Alonso, E., Fang, G., Ferrara, M., Hynd, G., & Porcelloni, M. (2001). Application of Chiral Sulfides to Catalytic Asymmetric Aziridination and Cyclopropanation with In Situ Generation of the Diazo Compound We thank Avecia (M.P.), the EPSRC (M.F.), the EU for a Marie Curie Fellowship (E.A.; HPMF-CT-1999-00076), Lu'an Teacher's College and the Education Minister of The Peoples Republic of China (G.F.), and Sheffield University for financial support. We thank Dr. J. Blacker (Avecia), Dr. R. V. H. Jones (Zeneca Agrochemicals), and Dr. R. Fieldhouse (Zeneca Agrochemica. Angewandte Chemie (International ed. in English), 40(8), 1433-1436.
Aggarwal, Varinder K., et al. "Application of Chiral Sulfides to Catalytic Asymmetric Aziridination and Cyclopropanation with In Situ Generation of the Diazo Compound We thank Avecia (M.P.), the EPSRC (M.F.), the EU for a Marie Curie Fellowship (E.A.; HPMF-CT-1999-00076), Lu'an Teacher's College and the Education Minister of The Peoples Republic of China (G.F.), and Sheffield University for financial support. We thank Dr. J. Blacker (Avecia), Dr. R. V. H. Jones (Zeneca Agrochemicals), and Dr. R. Fieldhouse (Zeneca Agrochemica." Angewandte Chemie (International ed. in English) vol. 40,8 (2001): 1433-1436.
Aggarwal VK, Alonso E, Fang G, Ferrara M, Hynd G, Porcelloni M. Application of Chiral Sulfides to Catalytic Asymmetric Aziridination and Cyclopropanation with In Situ Generation of the Diazo Compound We thank Avecia (M.P.), the EPSRC (M.F.), the EU for a Marie Curie Fellowship (E.A.; HPMF-CT-1999-00076), Lu'an Teacher's College and the Education Minister of The Peoples Republic of China (G.F.), and Sheffield University for financial support. We thank Dr. J. Blacker (Avecia), Dr. R. V. H. Jones (Zeneca Agrochemicals), and Dr. R. Fieldhouse (Zeneca Agrochemica. Angew Chem Int Ed Engl. 2001 Apr 17;40(8):1433-1436. PMID: 11317294.
Copy Download .nbib Format: NLM
Measurement of the Michel parameter rho in muon decay.

Physical review letters

Musser JR, Bayes R, Davydov YI, Depommier P, Doornbos J, Faszer W, Gagliardi CA, Gaponenko A, Gill DR, Green P, Gumplinger P, Hasinoff MD, Henderson RS, Hu J, Jamieson B, Kitching P, Koetke DD, Krushinsky AA, Lachin YY, Macdonald JA, MacDonald RP, Marshall GM, Mathie EL, Miasoedov LV, Mischke RE, Nord PM, Olchanski K, Olin A, Openshaw R, Porcelli TA, Poutissou JM, Poutissou R, Quraan MA, Rodning NL, Selivanov V, Sheffer G, Shin B, Sobratee F, Stanislaus TD, Tacik R, Torokhov VD, Tribble RE, Vasiliev MA, Wright DH.
PMID: 15783475
Phys Rev Lett. 2005 Mar 18;94(10):101805. doi: 10.1103/PhysRevLett.94.101805. Epub 2005 Mar 18.

The TWIST Collaboration has measured the Michel parameter rho in normal muon decay, mu(+)--> e(+)nu(e)nu (mu). In the standard model, rho = 3/4. Deviations from this value imply mixing of left- and right-handed muon and electron couplings. We find...

Cite
Musser JR, Bayes R, Davydov YI, et al. Measurement of the Michel parameter rho in muon decay. Phys Rev Lett. 2005;94(10):101805doi: 10.1103/PhysRevLett.94.101805.
Musser, J. R., Bayes, R., Davydov, Y. I., Depommier, P., Doornbos, J., Faszer, W., Gagliardi, C. A., Gaponenko, A., Gill, D. R., Green, P., Gumplinger, P., Hasinoff, M. D., Henderson, R. S., Hu, J., Jamieson, B., Kitching, P., Koetke, D. D., Krushinsky, A. A., Lachin, Y. Y., Macdonald, J. A., MacDonald, R. P., Marshall, G. M., Mathie, E. L., Miasoedov, L. V., Mischke, R. E., Nord, P. M., Olchanski, K., Olin, A., Openshaw, R., Porcelli, T. A., Poutissou, J. M., Poutissou, R., Quraan, M. A., Rodning, N. L., Selivanov, V., Sheffer, G., Shin, B., Sobratee, F., Stanislaus, T. D., Tacik, R., Torokhov, V. D., Tribble, R. E., Vasiliev, M. A., Wright, D. H. (2005). Measurement of the Michel parameter rho in muon decay. Physical review letters, 94(10), 101805. https://doi.org/10.1103/PhysRevLett.94.101805
Musser, J R, et al. "Measurement of the Michel parameter rho in muon decay." Physical review letters vol. 94,10 (2005): 101805. doi: https://doi.org/10.1103/PhysRevLett.94.101805
Musser JR, Bayes R, Davydov YI, Depommier P, Doornbos J, Faszer W, Gagliardi CA, Gaponenko A, Gill DR, Green P, Gumplinger P, Hasinoff MD, Henderson RS, Hu J, Jamieson B, Kitching P, Koetke DD, Krushinsky AA, Lachin YY, Macdonald JA, MacDonald RP, Marshall GM, Mathie EL, Miasoedov LV, Mischke RE, Nord PM, Olchanski K, Olin A, Openshaw R, Porcelli TA, Poutissou JM, Poutissou R, Quraan MA, Rodning NL, Selivanov V, Sheffer G, Shin B, Sobratee F, Stanislaus TD, Tacik R, Torokhov VD, Tribble RE, Vasiliev MA, Wright DH. Measurement of the Michel parameter rho in muon decay. Phys Rev Lett. 2005 Mar 18;94(10):101805. doi: 10.1103/PhysRevLett.94.101805. Epub 2005 Mar 18. PMID: 15783475.
Copy Download .nbib Format: NLM
Alzheimer's disease gene signature says: beware of brain viral infections.

Immunity & ageing : I & A

Porcellini E, Carbone I, Ianni M, Licastro F.
PMID: 21156047
Immun Ageing. 2010 Dec 14;7:16. doi: 10.1186/1742-4933-7-16.

BACKGROUND: Recent findings from a genome wide association investigation in a large cohort of patients with Alzheimer's disease (AD) and non demented controls (CTR) showed that a limited set of genes was in a strong association (p > l0-5)...

Cite
Porcellini E, Carbone I, Ianni M, et al. Alzheimer's disease gene signature says: beware of brain viral infections. Immun Ageing. 2010;7:16doi: 10.1186/1742-4933-7-16.
Porcellini, E., Carbone, I., Ianni, M., & Licastro, F. (2010). Alzheimer's disease gene signature says: beware of brain viral infections. Immunity & ageing : I & A, 716. https://doi.org/10.1186/1742-4933-7-16
Porcellini, Elisa, et al. "Alzheimer's disease gene signature says: beware of brain viral infections." Immunity & ageing : I & A vol. 7 (2010): 16. doi: https://doi.org/10.1186/1742-4933-7-16
Porcellini E, Carbone I, Ianni M, Licastro F. Alzheimer's disease gene signature says: beware of brain viral infections. Immun Ageing. 2010 Dec 14;7:16. doi: 10.1186/1742-4933-7-16. PMID: 21156047; PMCID: PMC3019140.
Copy Download .nbib Format: NLM
Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression.

Cancer cell international

Calogero A, Porcellini A, Lombari V, Fabbiano C, Arcella A, Miscusi M, Ponti D, Ragona G.
PMID: 21366897
Cancer Cell Int. 2011 Mar 02;11:5. doi: 10.1186/1475-2867-11-5.

BACKGROUND: Less than 30% of malignant gliomas respond to adjuvant chemotherapy. Here, we have asked whether variations in the constitutive expression of early-growth response factor 1 (EGR-1) predicted acute cytotoxicity and clonogenic cell death in vitro, induced by six...

Cite
Calogero A, Porcellini A, Lombari V, et al. Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression. Cancer Cell Int. 2011;11:5doi: 10.1186/1475-2867-11-5.
Calogero, A., Porcellini, A., Lombari, V., Fabbiano, C., Arcella, A., Miscusi, M., Ponti, D., & Ragona, G. (2011). Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression. Cancer cell international, 115. https://doi.org/10.1186/1475-2867-11-5
Calogero, Antonella, et al. "Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression." Cancer cell international vol. 11 (2011): 5. doi: https://doi.org/10.1186/1475-2867-11-5
Calogero A, Porcellini A, Lombari V, Fabbiano C, Arcella A, Miscusi M, Ponti D, Ragona G. Sensitivity to cisplatin in primary cell lines derived from human glioma correlates with levels of EGR-1 expression. Cancer Cell Int. 2011 Mar 02;11:5. doi: 10.1186/1475-2867-11-5. PMID: 21366897; PMCID: PMC3059282.
Copy Download .nbib Format: NLM
Breast fistula repair after autologous fat graft: a case report.

Case reports in medicine

Klinger FM, Caviggioli F, Forcellini D, Vinci V, Maione L, Pajardi G, Klinger M.
PMID: 21687540
Case Rep Med. 2011;2011:547387. doi: 10.1155/2011/547387. Epub 2011 Jun 07.

We report the case of a 55-year-old female patient who attended our clinic for the presence of a scar retraction in the upper pole of the left breast as a complication of breast augmentation. In the scar area, we...

Cite
Klinger FM, Caviggioli F, Forcellini D, et al. Breast fistula repair after autologous fat graft: a case report. Case Rep Med. 2011;2011:547387doi: 10.1155/2011/547387.
Klinger, F. M., Caviggioli, F., Forcellini, D., Vinci, V., Maione, L., Pajardi, G., & Klinger, M. (2011). Breast fistula repair after autologous fat graft: a case report. Case reports in medicine, 2011547387. https://doi.org/10.1155/2011/547387
Klinger, Francesco Maria, et al. "Breast fistula repair after autologous fat graft: a case report." Case reports in medicine vol. 2011 (2011): 547387. doi: https://doi.org/10.1155/2011/547387
Klinger FM, Caviggioli F, Forcellini D, Vinci V, Maione L, Pajardi G, Klinger M. Breast fistula repair after autologous fat graft: a case report. Case Rep Med. 2011;2011:547387. doi: 10.1155/2011/547387. Epub 2011 Jun 07. PMID: 21687540; PMCID: PMC3114542.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 193 entries